OCREVUS conc perf 300 mg/10 ml flac 10 ml
7680661850010
CH-66185
L04AA36
01.99.0.
Reimbursement limitations:
OCREVUS.01a
Pour le traitement des patients adultes atteints de formes actives de sclérose en plaques (SEP) …
1 / 3
google
Details
- Product number
- 6618501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ocrelizumabum 300 mg, natrii acetas trihydricus, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 3.6 mg.
Articles (1)
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5054.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2018
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 66185
- Drug name
- Ocrevus, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/09/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OCREVUS conc perf 300 mg/10 ml flac 10 ml
- Description (DE)
- OCREVUS Inf Konz 300 mg/10 ml Durchstf 10 ml
- Market launch
- 20/09/2017
- Narcotic (BTM)
- No